Journal of Urologic Oncology

Search

Page Path

HOME
Search

Prostate Cancer

Original Article

Efficacy of Topical Hemostatic Powder on Hemorrhagic Complications After Transrectal Prostate Biopsy: A Randomized Controlled Trial: Jung Hoon Kim, Yong Seong Lee, In Ho Chang, Tuan Thanh Nguyen, Se Young Choi; Journal of Urologic Oncology. 2026;24(1):13-20. Published online March 31, 2026; DOI: https://doi.org/10.22465/juo.255001160058; Full text PubReader ePub PDF

Kidney Cancer

Original Article

Global Renal Cell Carcinoma Research Trends Over 30 Years: A PRISMA-Compliant Bibliometric Analysis: Jung Hoon Kim, Ji Woong Hwang; Journal of Urologic Oncology. 2024;22(1):42-51. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600120006
Cited By 4; Full text PubReader ePub PDF

Review Article

The Present and Future of Intravesical Therapy in Bladder Cancer: Sin-Woo Seong, Youngjae Shin, In Ho Chang, Jung Hoon Kim; Korean J Urol Oncol. 2022;20(2):82-91. Published online May 26, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.2.82
Cited By 1; Full text PubReader ePub PDF

Erratum: Addition of the Co-author

Patient-Specific Tumor Microenvironment Models: Jung Woo Lee, Jia Kim, Youngjae Shin, Byung Hoon Chi, Jung Hoon Kim, In Ho Chang, Se Young Choi; Korean J Urol Oncol. 2022;20(1):69-69. Published online February 24, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.1.69
Corrects: 2021;19(4):197; Full text PubReader ePub PDF

Review Article

Patient-Specific Tumor Microenvironment Models: Jung Woo Lee, Jia Kim, Youngjae Shin, Byung Hoon Chi, Jung Hoon Kim, Se Young Choi; Korean J Urol Oncol. 2021;19(4):197-222. Published online November 25, 2021; DOI: https://doi.org/10.22465/kjuo.2021.19.4.197
Correction in: 2022;20(1):69
Cited By 1; Full text PubReader ePub PDF

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043

MOST READ MOST CITED

7,852	Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians
6,588	Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients
6,586	Nephron-Sparing Surgery for Upper Urinary Tract Urothelial Carcinoma
5,808	Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
5,701	Determinant of Aggressive Phenotype in Metastatic Hormone-Sensitive Prostate Cancer Depends on an Intrinsic, Highly Aggressive Cell Cluster: Integrated Single-Cell RNA and Whole Transcriptomic Sequencing Analyses

Cited By 9	Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion
Cited By 7	Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
Cited By 7	Trimodal Therapy in the Treatment of Muscle-Invasive Bladder Cancer
Cited By 4	Global Renal Cell Carcinoma Research Trends Over 30 Years: A PRISMA-Compliant Bibliometric Analysis
Cited By 4	Pathologic Diagnosis of Renal Cell Carcinoma in the Era of the 2022 World Health Organization Classification: Key Points for Clinicians

Editorial Office: Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817, FAX: +82-2-742-4665 Email: journal@e-juo.org

Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: leeseh@yuhs.ac

Copyright © The Korean Urological Oncology Society.